Article Information
vol. 8 no. 4
Published By
Online ISSN
History
- Received May 16, 2022
- Accepted July 5, 2022
- Published online October 17, 2022.
Article Versions
- previous version (August 18, 2022 - 07:22).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Rolof G.P. Gijtenbeek1,
- Vincent van der Noort2,
- Joachim G.J.V. Aerts3,
- Jeske A. Staal-van den Brekel4,
- Egbert F. Smit5,
- Frans H. Krouwels6,
- Frank A. Wilschut7,
- T. Jeroen N. Hiltermann8,
- Wim Timens9,
- Ed Schuuring9,
- Joost D.J. Janssen10,
- Martijn Goosens11,
- Paul M. van den Berg12,
- A. Joop de Langen13,
- Jos A. Stigt14,
- Ben E.E.M. van den Borne15,
- Harry J.M. Groen8,
- Wouter H. van Geffen1⇑ and
- Anthonie J. van der Wekken8
- 1Dept of Respiratory Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
- 2Dept of Biometrics, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands
- 3Dept of Pulmonary Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands
- 4Dept of Respiratory Medicine, Hospital Group Twente, Almelo/Hengelo, The Netherlands
- 5Dept of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands
- 6Dept of Respiratory Medicine, Spaarne Hospital, Hoofddorp, The Netherlands
- 7Dept of Respiratory Medicine, Gelderse Vallei Hospital, Ede, The Netherlands
- 8Dept of Pulmonary Diseases, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands
- 9Dept of Pathology and Medical Biology, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands
- 10Dept of Respiratory Medicine, Máxima Medical Centre, Eindhoven/Veldhoven, The Netherlands
- 11Dept of Pulmonary Medicine, Gelre Hospitals, Zutphen, The Netherlands
- 12Dept of Respiratory Medicine, Maasstad Hospital, Rotterdam, The Netherlands
- 13Dept of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 14Dept of Respiratory Medicine, Isala Hospital, Zwolle, The Netherlands
- 15Dept of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands
- Corresponding author: Wouter H. van Geffen (wouter.van.geffen{at}mcl.nl)
Funding
Roche Nederland
Eli Lilly and Company
Amgen
Article usage
Altmetrics
Vol 8 Issue 4
Table of Contents
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
